Total Payments
$262,541
2024 Payments
$35,436
Companies
26
Transactions
535
Medicare Patients
3,018
Medicare Billing
$310,105
Payment Breakdown by Category
Other$224,310 (85.4%)
Consulting$16,594 (6.3%)
Travel$12,172 (4.6%)
Food & Beverage$9,401 (3.6%)
Gifts$47.09 (0.0%)
Education$16.05 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $213,827 | 106 | 81.4% |
| Consulting Fee | $16,594 | 10 | 6.3% |
| Travel and Lodging | $12,172 | 44 | 4.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,200 | 4 | 3.9% |
| Food and Beverage | $9,401 | 366 | 3.6% |
| Entertainment | $283.03 | 2 | 0.1% |
| Gift | $47.09 | 1 | 0.0% |
| Education | $16.05 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $102,882 | 198 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $61,493 | 65 | $0 (2022) |
| Janssen Biotech, Inc. | $37,478 | 75 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $32,070 | 21 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $11,904 | 22 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $9,033 | 30 | $0 (2024) |
| Prometheus Laboratories Inc. | $4,730 | 10 | $0 (2018) |
| Celgene Corporation | $993.17 | 8 | $0 (2024) |
| Romark Laboratories, LC | $678.47 | 11 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $321.36 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,436 | 61 | Janssen Biotech, Inc. ($23,197) |
| 2023 | $25,256 | 40 | AbbVie Inc. ($11,817) |
| 2022 | $29,091 | 43 | E.R. Squibb & Sons, L.L.C. ($11,534) |
| 2021 | $29,826 | 57 | E.R. Squibb & Sons, L.L.C. ($13,964) |
| 2020 | $22,659 | 30 | Janssen Scientific Affairs, LLC ($13,206) |
| 2019 | $26,229 | 67 | AbbVie, Inc. ($14,361) |
| 2018 | $31,072 | 81 | AbbVie, Inc. ($17,221) |
| 2017 | $62,971 | 156 | AbbVie, Inc. ($31,570) |
All Payment Transactions
535 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $99.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | STELARA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | STELARA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,250.00 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $93.13 | General |
| Category: Immunology | ||||||
| 10/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,250.00 | General |
| Category: Immunology | ||||||
| 10/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 10/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $88.18 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Immunology | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,841.00 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 699 | 730 | $246,843 | $74,542 |
| 2022 | 12 | 781 | 802 | $333,658 | $78,134 |
| 2021 | 13 | 887 | 917 | $394,567 | $90,421 |
| 2020 | 11 | 651 | 710 | $282,086 | $67,008 |
Total Patients
3,018
Total Services
3,159
Medicare Billing
$310,105
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 168 | 168 | $72,576 | $18,648 | 25.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 196 | 202 | $59,994 | $14,337 | 23.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 72 | 73 | $40,077 | $14,217 | 35.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 35 | 35 | $12,213 | $5,723 | 46.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 70 | 86 | $11,782 | $5,128 | 43.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 51 | $13,209 | $5,001 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 36 | $8,748 | $3,165 | 36.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $6,196 | $2,952 | 47.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $6,766 | $2,318 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,770 | $1,850 | 38.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $3,168 | $998.67 | 31.5% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $7,344 | $205.13 | 2.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 134 | 134 | $83,712 | $15,860 | 18.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 195 | 200 | $96,525 | $13,307 | 13.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 57 | 57 | $43,567 | $10,751 | 24.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 85 | 87 | $22,716 | $8,606 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 82 | 82 | $25,580 | $8,050 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 75 | $15,888 | $5,962 | 37.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 27 | 27 | $9,758 | $4,715 | 48.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 73 | $10,113 | $3,933 | 38.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 14 | 14 | $5,055 | $2,448 | 48.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $9,343 | $2,298 | 24.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 13 | 13 | $4,375 | $1,242 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 11 | $1,730 | $824.36 | 47.7% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 11 | 12 | $5,296 | $137.33 | 2.6% |
About Dr. Jeffrey Tuvlin, MD
Dr. Jeffrey Tuvlin, MD is a Gastroenterology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033215520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Tuvlin, MD has received a total of $262,541 in payments from pharmaceutical and medical device companies, with $35,436 received in 2024. These payments were reported across 535 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($213,827).
As a Medicare-enrolled provider, Tuvlin has provided services to 3,018 Medicare beneficiaries, totaling 3,159 services with total Medicare billing of $310,105. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Louisville, KY
- Active Since 09/15/2006
- Last Updated 11/19/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1033215520
Products in Payments
- STELARA (Biological) $73,421
- Humira (Biological) $50,611
- ZEPOSIA (Drug) $32,163
- TREMFYA (Drug) $20,649
- SKYRIZI (Biological) $15,739
- HUMIRA (Biological) $14,953
- Entyvio (Biological) $8,997
- RINVOQ (Biological) $8,989
- APRISO (Drug) $6,879
- UCERIS (Drug) $4,996
- REMICADE (Biological) $4,902
- Alinia Tablets 500mg 30 count bottle (Drug) $667.08
- XELJANZ (Drug) $206.04
- XIFAXAN (Drug) $189.32
- LINZESS (Drug) $120.43
- VIBERZI (Drug) $69.66
- Cimzia (Drug) $66.91
- XIFAXANIBSD (Drug) $66.81
- OCALIVA (Drug) $64.94
- DUPIXENT (Biological) $61.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Louisville
Gerald Dryden, Md, MD
Gastroenterology — Payments: $2.6M
Gastroenterology $2.6M
Dr. Sunana Sohi, M.d, M.D
Gastroenterology — Payments: $190,137
Gastroenterology $190,137
Dr. Michael Krease, D.o, D.O
Gastroenterology — Payments: $161,937
Gastroenterology $161,937
Stephen Mcclave, Md, MD
Gastroenterology — Payments: $147,518
Gastroenterology $147,518
Ashwani Singal, M.d.; M.sc, M.D.; M.SC
Gastroenterology — Payments: $42,847
Gastroenterology $42,847
Dr. Thomas Abell, Md, MD
Gastroenterology — Payments: $38,709
Gastroenterology $38,709